Mutoh Tetsuji, Chun Jerold
Department of Molecular Biology, Helen L. Dorris Child and Adolescent Neuropsychiatric Disorder Institute, The Scripps Research Institute, 10550 North Torrey Pines Rd., ICND-118, La Jolla, CA 92037, USA.
Subcell Biochem. 2008;49:269-97. doi: 10.1007/978-1-4020-8831-5_10.
One of the major lipid biology discoveries in last decade was the broad range of physiological activities of lysophospholipids that have been attributed to the actions of lysophospholipid receptors. The most well characterized lysophospholipids are lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P). Documented cellular effects of these lipid mediators include growth-factor-like effects on cells, such as proliferation, survival, migration, adhesion, and differentiation. The mechanisms for these actions are attributed to a growing family of 7-transmembrane, G protein-coupled receptors (GPCRs). Their pathophysiological actions include immune modulation, neuropathic pain modulation, platelet aggregation, wound healing, vasopressor activity, and angiogenesis. Here we provide a brief introduction to receptor-mediated lysophospholipid signaling and physiology, and then discuss potential therapeutic roles in human diseases.
过去十年脂质生物学的重大发现之一是溶血磷脂具有广泛的生理活性,这些活性归因于溶血磷脂受体的作用。特征最明确的溶血磷脂是溶血磷脂酸(LPA)和1-磷酸鞘氨醇(S1P)。这些脂质介质已被证明的细胞效应包括对细胞的生长因子样作用,如增殖、存活、迁移、黏附和分化。这些作用的机制归因于一个不断增加的7次跨膜G蛋白偶联受体(GPCR)家族。它们的病理生理作用包括免疫调节、神经性疼痛调节、血小板聚集、伤口愈合、血管加压活性和血管生成。在此,我们简要介绍受体介导的溶血磷脂信号传导和生理学,然后讨论其在人类疾病中的潜在治疗作用。